Hemodynamic management of sepsis-induced circulatory failure is complex since this pathological state includes multiple cardiovascular derangements that can vary from patient to patient according to the degree of hypovolemia, of vascular tone depression, of myocardial depression and of microvascular dysfunction. The treatment of the sepsis-induced circulatory failure is thus not univocal and should be adapted on an individual basis. As physical examination is insufficient to obtain a comprehensive picture of the hemodynamic status, numerous hemodynamic variables more or less invasively collected, have been proposed to well assess the severity of each component of the circulatory failure and to monitor the response to therapy. In this article, we first describe the hemodynamic variables, which are the most relevant to be used, emphasizing on their physiological meaning, their validation and their limitations in patients with septic shock. We then proposed a general approach for managing patients with septic shock by describing the logical steps that need to be followed in order to select and deliver the most appropriate therapies. This therapeutic approach is essentially based on knowledge of physiology, of pathophysiology of sepsis, and of published data from clinical studies that addressed the issue of hemodynamic management of septic shock.
Introduction
Septic shock is characterized by multiple cardiovascular abnormalities including absolute and relative hypovolemia, vascular tone depression, myocardial dysfunction, derangements in regional blood flow distribution and microcirculatory disorders. Septic shock is often associated with multiple organ failure, including mainly respiratory and renal failures. The degree of severity of each of these disorders is variable from patient to patient. Early and adequate hemodynamic support is crucial to prevent further worsening of organ dysfunction. Therefore, it is important to assess the degree of each component of the hemodynamic failure in order to select the appropriate therapeutic measures. Multiple hemodynamic variables are available to manage patients with septic shock. The main issue for the physician is to properly integrate these variables in order to optimize the therapy. Some of the hemodynamic variables are used to make or confirm the diagnosis of shock and others are used to guide therapy and to evaluate the response to it. In this review, we describe a wide variety of hemodynamic variables and we propose how to integrate them in a theracc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. activate the sodium-potassium-adenosine triphosphatase (Na-K-ATPase) activity and this increased the glycolytic flux. [3] These results are supported by the observation that lactate production is reduced by β 2 -receptors antagonists such as esmolol and by Na/K-ATPase inhibitors (ouabain) in septic shock or when glycolysis is induced by epinephrine. [4] Finally, hyperlactatemia might also be the result of impaired lactate clearance during sepsis.
[5] This may become an important issue in patients with significant pre-existing or new hepatic dysfunction.
2) Arterial blood pressure
Arterial catheterization (radial or femoral artery) is recommended as soon as possible during acute circulatory failure to monitor the arterial pressure waveform in realtime and also to easily sample arterial blood. [6, 7] This provides direct measurements of systolic arterial pressure There was no difference between the two groups in 28-day mortality rates. [9] There was no difference either in the overall rate of serious adverse events, except a slightly higher rate of atrial fibrillation in the high MAP target group. [9] In the predefined stratum of patients with chronic hypertension, those with a MAP target of 80-85 mmHg exhibited a more pronounced improvement in renal function and fewer requirements for renal replacement therapy. [9] This study thus suggests that in patients with history of chronic hypertension, a MAP between 80-85 mmHg is a reasonable target. A MAP target higher than 65 mmHg should also be considered in cases of high central venous pressure (CVP), which reflects a high outflow venous pressure within organs. Indeed, in such cases, it could be important either to increase the MAP or to decrease CVP in order to maintain an adequate driving pressure for organ perfusion. Similarly, in intraabdominal hypertension syndromes, the increased intraabdominal pressure can represent the outflow pressure of intra-abdominal organs, necessitating then a higher than normal MAP target to preserve their adequate perfusion unless therapeutic reduction of the intra-abdominal pressure is feasible.
(2) Diastolic arterial pressure
The DAP is also important to monitor since it is the driving pressure for the left ventricular perfusion. In addition, DAP is a marker of arterial tone. It is also influenced by arterial compliance and heart rate. A low DAP can thus exist in cases of decreased vasomotor tone (e.g. sepsis), reduced arterial compliance and bradycardia.
Therefore, in case of sepsis with tachycardia, a low DAP (i.e. < 40 mmHg) is an indicator of a profoundly depressed arterial tone.
(3) Pulse pressure
At the level of aorta, PP is dependent on stroke volume and arterial stiffness. Due to the pulse wave amplification (PWA) phenomenon, which increases the peripheral PP compared to the aortic PP, the relation between peripheral PP and stroke volume is weaker except in old patients or in those with chronic hypertension, diabetes or arteriosclerosis, in whom the PWA is minimal. In those patients, PP should be higher than normal (60-80 mmHg) if stroke volume is normal due of the increased arterial stiffness. Thus, a lower than normal PP (30-40 mmHg) in such patients means than stroke volume is low.
3) The mixed venous blood oxygen saturation (SvO 2 ) and the central venous oxygen saturation (ScvO 2 )
The SvO 2 , which is measured in the mixed venous and Hb, the value of SvO 2 ranges from 70 to 75%. SvO 2 can be considered as a marker of oxygen extraction. Indeed, the whole-body oxygen extraction ratio (OER) is defined as the ratio of the whole-body VO 2 to the wholebody DO 2 : OER = VO 2 /DO 2 . As DO 2 equals approximately CO × Hb × 13.4, then SvO 2 equals SaO 2 -(VO 2 / DO 2 ). When SaO 2 is close to 1 (100%), SvO 2 can thus be used to estimate OER: SvO 2 = 1 -OER.
By considering that SvO 2 reflects OER, SvO 2 changes can be interpreted as follows:
A decrease in SvO 2 means that OER has increased to make the whole-body VO 2 matched with the wholebody oxygen demand. This increase in OER can be trig-gered by either a drop in DO 2 , or an increase in oxygen demand, or both. If, in spite of this normal adaptation, VO 2 does not match oxygen demand, tissue hypoxia and anaerobic metabolism appear. [10] However, no precise value of SvO 2 , can be defined as the "critical" SvO 2 below which tissue hypoxia occurs. [10] Conversely, an increase in SvO 2 means that OER has decreased as a consequence of either an increase in DO 2 with maintained VO 2 or a decrease in VO 2 with maintained or increased DO 2 . This latter situation is typically encountered in hyperdynamic septic shock, where the decrease in VO 2 (despite a high whole-body oxygen demand) does not result from a reduced DO 2 , but rather from impairment of the O 2 extraction capabilities. These points underline the fact that: 1) SvO 2 cannot be a reliable marker of the adequacy between DO 2 and global oxygen demand in shock states, where VO 2 is lower than oxygen demand, and 2) interpretation of SvO 2 can be misleading in hyperdynamic states. [11] Finally, it should be kept in mind that during resuscitation of shock states, increase in DO 2 is expected to result in parallel increase in VO 2 such that SvO 2 does not change markedly unless a critical level of DO 2 is reached. Above this critical level of DO 2 , a further increase in DO 2 is associated with a marked increase in ScvO 2 but no anymore change in VO 2 . [11] Due to the decline of the use of the pulmonary artery catheter, ScvO 2 has been proposed to replace SvO 2 , as a central venous catheter is recommended to be used in shock states. [6, 7] Studies comparing SvO 2 and ScvO 2 generally found satisfactory results in terms of absolute values [12] as well as in terms of trends. [13] Confirmation of the interest of ScvO 2 in the resuscitation of septic shock patients was brought by the Rivers et al's study, [14] where a therapeutic strategy (called early goal-directed therapy) aimed at targeting a ScvO 2 value > 70% during initial resuscitation was shown to result in a better outcome than standard care. [14] Although recent multicenter randomized clinical trials did not confirm these findings, [15] it must be emphasized that ScvO 2 was already higher than the 70% target in the vast majority of the included patients so that these trials could not by nature showed any benefit of EGDT.
4) Mixed venous blood (or central venous blood) minus arterial blood carbon dioxide (CO 2 ) pressures differences
The Fick equation applied to CO 2 indicates that the CO 2 excretion (equivalent to CO 2 production (VCO 2 ) in a steady-state) equals the product of CO by the difference between the CO 2 content in the mixed venous blood and in the arterial blood. The normal relationship between CO 2 content and CO 2 pressure is almost linear over the usual physiological range of the CO 2 contents. Thus, by substituting CO 2 pressure for CO 2 content , the mixed venous blood -arterial blood PCO 2 difference (also called PCO 2 gap) equals k × VCO 2 / CO, where k is a factor defining the relationship between CO 2 content and CO 2 pressure. [16] The relationship between CO and CO 2 pressure is explained by the CO 2 stagnation phenomenon that increases the venous blood CO 2 pressure relatively to the arterial blood CO 2 pressure at the peripheral venous level. Thus, a low CO and hence a low efferent venous blood flow should decrease the CO 2 clearance rate and should result in an increased PCO 2 gap for a given VCO 2 .
In normal conditions, PCO 2 gap values range between 2 and 6 mmHg. Accordingly, in a clinical study performed in normolactatemic patients with low cardiac index at baseline, the increase in cardiac index from 1.6 to 2.2 L.min -1 .m -2 was accompanied by a decrease in PCO 2 gap from 9 to 5 mmHg, while VO 2 (and thus probably VCO 2 ) was unchanged. [17] In patients with tissue hypoxia, two situations should be distinguished in function of the systemic blood flow.
In case of tissue hypoxia with reduced systemic blood flow, PCO 2 gap should increase, whereas in case of tissue hypoxia with maintained or high systemic blood flow, PCO 2 gap should be normal. [18, 19] . In the latter conditions, the high venous blood flow can easily remove the low amount of CO 2 produced at the periphery.
In summary, regardless of the presence of tissue hypoxia, a normal PCO 2 gap (≤ 6 mmHg) is expected if CO is normal or high, and a high PCO 2 (> 6 mmHg)
is expected if CO is too low. Thus, a normal PCO 2 gap suggests that elevation of CO cannot be a priority in the therapeutic strategy, whereas a high PCO 2 gap suggests that elevation of CO may be a good therapeutic option.
5) Dynamic variables and tests predicting fluid responsiveness
The concept of prediction of fluid responsiveness has emerged since it has been demonstrated that only 50%
of patients with acute circulatory failure respond to fluid administration in terms of increase in CO [20] and that fluid overload is associated with increased mortality. [21] During the last fifteen years, a number of indices able to predict fluid responsiveness at the bedside have been developed. In patients receiving mechanical ventilation, indices based on heart-lung interactions and mainly the respiratory variation of surrogates of stroke volume have been proposed. [22] The general principle is that when the heart is preload responsive, the stroke volume -or a surrogate such as PP -varies markedly over the respiratory cycle.
[22] Accordingly, pulse pressure variation (PPV) was found to predict responsiveness better than cardiac filling pressures in patients with septic shock.
[23] A metaanalyse including more than 800 patients
showed that the prediction of fluid responsiveness by PPV is excellent in various clinical conditions with a cutoff of 12%. [24] In other words, when PPV is > 12%, CO is likely to increase by more than 15% if fluid is infused (fluid responsiveness), whereas if PPV is < 12%, no increase in CO can be expected from fluid infusion (fluid unresponsiveness). Recent functional hemodynamic monitoring devices calculate PPV automatically from the arterial pressure curve recording and display its value in real-time on their screen. Other fluid responsiveness indices such as stroke volume variation (SVV) can also been calculated and displayed by some advanced hemodynamic monitors but they have no superiority over PPV, [25] which has the great advantage to be recorded from a simple arterial catheter. However, the applicability of PPV (or SVV) for predicting fluid responsiveness is limited in the intensive care unit since it cannot be used in cases of spontaneous breathing activity, cardiac arrhythmias, low tidal volume ventilation and low lung compliance. [26] Other tests such as passive leg raising (PLR) [27] reliably predict fluid responsiveness, [28] in particular in situations where PPV fails to do it. [29, 30] Strict rules must be respected for the PLR being adequately interpreted.
[27] Among them, the need of a real-time CO measurement must be emphasized. Real-time CO monitors using the arterial pressure waveform-based CO [31] as well as echocardiography (velocity-time integral) [32] are particularly suitable.
6) Transpulmonary thermodilution variables
Transpulmonary thermodilution systems have been developed in the last fifteen years and are currently recommended to be used in complex patients, especially in those with circulatory shock and associated ARDS. [6, 7] 
How can clinicians integrate the hemodynamic variables to manage patients with septic shock?
The Fig. 1 To select the most appropriate treatment for increasing MAP, it is then essential to pay attention to the DAP.
A low DAP is generally due to a low arterial tone and thus should prompt a vasopressive therapy urgently. As already mentioned, a low heart rate also can be responsible for lowering DAP. As a direct consequence, a low DAP in presence of tachycardia suggests that the arterial tone is totally depressed and that vasopressors should be administered in extreme urgency. When a vasopressor is administered (mainly norepinephrine), the MAP target should be individualized. [6, 39] In the context of septic shock [8] or cardiogenic shock, [40] the initial MAP target should be at least 65 mmHg. The MAP target should be higher in case of history of chronic hypertension, [6, 8, 9, 39] increased CVP or increased intra-abdominal pressure.
If the DAP is not judged as low, the low MAP is likely to be associated with an insufficient (CO) (see below).
The presence of a low PP could be an additional indication of low stroke volume, although a low stroke volume can be associated with normal PP in patients having stiff arteries. In patients with shock, ScvO 2 can be low (< 70%), normal (between 70 and 80%) or high (> 80%) depending on the value of DO 2 and the degree of alteration of oxygen extraction capabilities.
When ScvO 2 is low, as DO 2 is inadequate to VO 2 , it is logical to attempt to increase DO 2 , especially in such conditions of oxygen debt, where VO 2 does not meet oxygen demand.
-If Hb is low, blood transfusion can be considered.
-If Hb is not low, the insufficient DO 2 should be due to an insufficient CO, either related to insufficient preload or to altered cardiac contractility. Cardiac function should be rapidly assessed by transthoracic echocardiography, which helps diagnose left ventricular dysfunction using left ventricular ejection fraction (LVEF). A low LVEF (< 45%) strongly suggests that septic shock is associated with myocardial depression and in this context, administration of an inotropic drug can be considered.
Right ventricular dysfunction can be suspected when the right ventricular end-diastolic area/left ventricular enddiastolic area ratio is high (> 0.6). [41] A specific treatment can be initiated after determination of the precise underlying mechanism (mainly using echocardiography).
If cardiac function is unaltered and Hb not low, the low [32] In the presence of fluid responsiveness, administration of fluids should be considered. However, as for any other therapeutic intervention, the benefit/risk ratio of fluid infusion should be individually assessed. In patients with acute respiratory distress syndrome (ARDS), the risk of worsening pulmonary edema with fluid infusion is increased due to increased permeability of the lung capillary membrane. Knowledge of EVLW and PVPI, which as good markers of pulmonary edema and of capillary leakage are helpful to assess risk of fluid infusion in such circumstances. [33] Alternatively, pulmonary artery catheterization can be considered in such complex cases. [6, 7] The value of the pulmonary artery occlusion pressure can then be taken for assessing the risk of pulmonary edema formation during fluid infusion, although it is neither a marker of the volume of pulmonary edema nor of the degree of capillary leakage. Nevertheless, these advanced hemodynamic monitoring systems are relatively invasive and costly and should be reserved to situations where shock is associated with ARDS or in case of insufficient response to the initial treatment of shock. [6, 7] These devices are thus particularly helpful to assess the benefit/ risk ratio of fluid infusion in complex situations.
It is noteworthy that in the rare cases of preload unresponsiveness despite low ScvO 2 , normal cardiac function and normal Hb, it would be important to reconsider the MAP target and attempt to reach a higher value.
Presence of a normal ScvO 2 while tissue hypoxia persists strongly suggests that the oxygen extraction capabilities are altered. Nevertheless, it has been clearly shown that in patients with persistent shock, hyperlactatemia 
Conclusion
Hemodynamic management of sepsis-induced circulatory failure is complex since this pathological state includes multiple cardiovascular derangements that can vary from patient to patient. To make the correct therapeutic decision, clinicians need to be helped by hemodynamic variables other than those obtained from the clinical examination. Integration of these hemodynamic variables in a logical scheme is helpful to identify the main(s) hemodynamic disorder(s) and to assess the benefit/risk ratio of each therapeutic intervention at any time of the resuscitation phase.
